Evidence map›Paper›PMID 35406433›Full record

ArticleCancers2022

Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts.

Franck Talmont, Elodie Mitri, Christine Dozier, Arnaud Besson, Olivier Cuvillier, Anastassia Hatzoglou

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Franck TalmontInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 31059 Toulouse, France.ORCID 0000-0003-4933-5816
Elodie MitriMolecular, Cellular and Developmental Biology (MCD), Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062 Toulouse, France.
Christine DozierMolecular, Cellular and Developmental Biology (MCD), Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062 Toulouse, France.
Arnaud BessonMolecular, Cellular and Developmental Biology (MCD), Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, 31062 Toulouse, France.ORCID 0000-0002-9599-3943
Olivier CuvillierInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 31059 Toulouse, France.ORCID 0000-0003-3346-375X
Anastassia HatzoglouInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 31059 Toulouse, France.ORCID 0000-0001-7177-6808
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sphingosine 1-phosphate (S1P), a bioactive lipid, interacts with five widely expressed G protein-coupled receptors (S1P1-5), regulating a variety of downstream signaling pathways with overlapping but also opposing functions. To date, data regarding the role of S1P5 in cell proliferation are ambiguous, and its role in controlling the growth of untransformed cells remains to be fully elucidated. In this study, we examined the effects of S1P5 deficiency on mouse embryonic fibroblasts (MEFs). Our results indicate that lack of S1P5 expression profoundly affects cell morphology and proliferation. First, S1P5 deficiency reduces cellular senescence and promotes MEF immortalization. Second, it decreases cell size and leads to cell elongation, which is accompanied by decreased cell spreading and migration. Third, it increases proliferation rate, a phenotype rescued by the reintroduction of exogenous S1P5. Mechanistically, S1P5 promotes the activation of FAK, controlling cell spreading and adhesion while the anti-proliferative function of the S1P/S1P5 signaling is associated with reduced nuclear accumulation of activated ERK. Our results suggest that S1P5 opposes the growth-promoting function of S1P1-3 through spatial control of ERK activation and provides new insights into the anti-proliferative function of S1P5.

Indexed as

cell migrationcell proliferationcell spreadingERKFAKMEF immortalizationS1P5sphingosine-1phosphate

Identifiers

PMID35406433
PMCPMC8996878
OpenAlexW4220838530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.